370 related articles for article (PubMed ID: 7530868)
1. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
2. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
[TBL] [Abstract][Full Text] [Related]
3. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
4. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
[TBL] [Abstract][Full Text] [Related]
5. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
Platz KP; Mueller AR; Blumhardt G; Bachmann S; Bechstein WO; Kahl A; Neuhaus P
Transplantation; 1994 Jul; 58(2):170-8. PubMed ID: 7518975
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Raofi V; Holman DM; Coady N; Vazquez E; Dunn TB; Bartholomew AM; Pollak R; Benedetti E
Am J Surg; 1999 Apr; 177(4):299-302. PubMed ID: 10326847
[TBL] [Abstract][Full Text] [Related]
8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group.
Pirsch JD
Transplantation; 1999 Oct; 68(8):1203-5. PubMed ID: 10551653
[TBL] [Abstract][Full Text] [Related]
11. Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group.
Devlin J; Williams R
Transplantation; 1996 Nov; 62(9):1251-5. PubMed ID: 8932266
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
[TBL] [Abstract][Full Text] [Related]
14. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
[TBL] [Abstract][Full Text] [Related]
15. Management of acute steroid-resistant rejection after liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lemmens P; Lobeck H; Neuhaus P
World J Surg; 1996 Oct; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
[TBL] [Abstract][Full Text] [Related]
16. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
17. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
Hadley S; Samore MH; Lewis WD; Jenkins RL; Karchmer AW; Hammer SM
Transplantation; 1995 Mar; 59(6):851-9. PubMed ID: 7535482
[TBL] [Abstract][Full Text] [Related]
18. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
Wiesner RH
Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group.
Klein A
Liver Transpl Surg; 1999 Nov; 5(6):502-8. PubMed ID: 10545538
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.
Sakr M; Hassanein T; Gavaler J; Abu-Elmagd K; Fung J; Gordon R; Starzl T; Van Thiel D
Transplantation; 1992 Apr; 53(4):786-91. PubMed ID: 1373535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
